Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Completed × Fluoxetine × Clear all

Phase

Phase NA 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Advanced Cancer 1

Interventions

Exercise 212 Blood Specimen Collection 120 Surveys and Questionnaires 114 Standard of Care 114 Magnetic Resonance Spectroscopy 112 Early Intervention, Educational 107 Educational Status 102 Methods 101 Radiotherapy 92 Radiosurgery 75 Counseling 71 Control Groups 63 Acupuncture Therapy 60 Biopsy 59 Therapeutics 56 Psychiatric Rehabilitation 54 Resistance Training 51 Saline Solution 48 Cyclophosphamide 48 Palliative Care 46 Practice Guidelines as Topic 41 Cognitive Behavioral Therapy 41 Yoga 40 Metformin 39 Interviews as Topic 39 Drug Therapy 37 Surgical Procedures, Operative 36 Radiofrequency Ablation 35 Dexmedetomidine 35 Colonoscopy 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00512291 2011-09-27

Subcutaneous Olanzapine for Hyperactive or Mixed Delirium

M.D. Anderson Cancer Center

Phase NA Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡